Glenford Pharmaceuticals Private Limited

Pharmaceutical company providing various medicines, established in 2019 and based in Delhi.

2019 | Delhi (India) | Active
Last Updated:

Glenford Pharmaceuticals Profile

Key Indicators

  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 5 Year, 3 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 7.70 M
  • Revenue Growth 49.94%
  • Profit Growth 16.58%
  • Ebitda 650.06%
  • Net Worth 113.30%
  • Total Assets 42.07%

About Glenford Pharmaceuticals

Glenford Pharmaceuticals Private Limited (GPPL) is a Private Limited Indian Non-Government Company incorporated in India on 18 November 2019 (Five years and three months 17 days old ). Its registered office is in Delhi, India.

The Company is engaged in the Pharma Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.

The company currently has active open charges totaling ₹7.70 M.

Beenu Jain and Mohit Saini serve as directors at the Company.

Company Details

  • Location

    Delhi, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

    -

  • Social Media
    -

Corporate Identity Details

  • CIN/LLPIN

    U51909DL2019PTC357636

  • Company No.

    357636

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    18 Nov 2019

  • Date of AGM

    30 Sep 2024

  • Date of Balance Sheet

    31 Mar 2024

  • Listing Status

    Unlisted

  • ROC Code

    Roc Delhi

Industry

Pharma

Who are the key members and board of directors at Glenford Pharmaceuticals?

Board Members (2)

NameDesignationAppointment DateStatus
Beenu Jain Country flag representing In Director 18-Nov-2019Current
Mohit Saini Country flag representing In Director 02-Mar-2021Current

Financial Performance of Glenford Pharmaceuticals.

Glenford Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 49.94% increase. The company also saw a substantial improvement in profitability, with a 16.58% increase in profit. The company's net worth Soared by an impressive increase of 113.3%.

Glenford Pharmaceuticals revenue growth over time
Glenford Pharmaceuticals profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
49.94%
Revenue from Operations
49.91%
Total Assets
42.07%
Profit or Loss
16.58%
Net Worth
113.30%
EBITDA
650.06%

What is the Ownership and Shareholding Structure of Glenford Pharmaceuticals?

Unlock access to Glenford Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Indicator graph

Charges (Loans)

Open Charges

₹7.70 M

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions

  • Hdfc Bank Limited : 0.77 Cr

Latest Charge Details

DateLenderAmountStatus
01 Jan 2024Hdfc Bank Limited₹7.70 MOpen

How Many Employees Work at Glenford Pharmaceuticals?

Unlock and access historical data on people associated with Glenford Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee growth trends for Glenford Pharmaceuticals Private Limited

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Glenford Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Glenford Pharmaceuticals's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Glenford Pharmaceuticals

Recent activity within the organization

  • Annual General Meeting

    Glenford Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.

  • Balance Sheet

    Glenford Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi.

  • Charges

    A charge with Hdfc Bank Limited amounted to Rs. 7.70 M with Charge ID 100855530 was registered on 01 Jan 2024.

  • Director Appointment

    Mohit Saini was appointed as a Director was appointed as a Director on 02 Mar 2021 & has been associated with this company since 4 years 2 days .

  • Director Appointment

    Beenu Jain was appointed as a Director was appointed as a Director on 18 Nov 2019 & has been associated with this company since 5 years 3 months .

  • Company Incorporation

    Glenford Pharmaceuticals Private Limited was registered on 18 Nov 2019 with Roc Delhi & aged 5 years 3 months as per MCA records.

Frequently asked questions

  • What is the Incorporation or founding date of Glenford Pharmaceuticals Private Limited?

    Glenford Pharmaceuticals Private Limited was incorporated on 18 Nov 2019.

  • What is authorized share capital and paid-up capital of Glenford Pharmaceuticals Private Limited?

    The authorized share capital of Glenford Pharmaceuticals Private Limited is ₹ 0.10 M and paid-up capital is ₹ 0.10 M.

  • Who are the current board members & directors of Glenford Pharmaceuticals Private Limited?

    Currently 2 directors are associated with Glenford Pharmaceuticals Private Limited.

    • Beenu Jain
    • Mohit Saini

  • What is the registered address of Glenford Pharmaceuticals Private Limited?

    As per Ministry of Corporate Affairs (Mca), the registered address of Glenford Pharmaceuticals Private Limited is 1/6464, 2Nd Floor East Rohtash Nagar India, Shahdara, Delhi, 110032.

  • What is the corporate identification number (CIN) and company number of Glenford Pharmaceuticals Private Limited?

    The corporate identification number (CIN) of Glenford Pharmaceuticals Private Limited is U51909DL2019PTC357636 and the company number is 357636 as per Ministry of Corporate Affairs (MCA).

  • What has been the recent revenue trend for Glenford Pharmaceuticals Private Limited?

    According to the financial reports for the fiscal year 2023, the revenue trend for Glenford Pharmaceuticals Private Limited has risen by 49.94%.

  • What change has been observed in the net worth of Glenford Pharmaceuticals Private Limited, and by what percentage?

    The financial reports for the fiscal year 2023 indicates that The net worth of Glenford Pharmaceuticals Private Limited has experienced an upsurge of 113.30%.

  • What are the total open charges for Glenford Pharmaceuticals Private Limited?

    As per the financial statements for fiscal Year 2023, The total open charges for Glenford Pharmaceuticals Private Limited amount to ₹ 7.70 M.

  • When was the last Balance Sheet of Glenford Pharmaceuticals Private Limited filed with the ROC?

    The most recent Balance Sheet for Glenford Pharmaceuticals Private Limited was filed with the ROC on 31 Mar 2024.

People also Viewed

Similar Companies Based on Pharmaceutical Retailers & Distributors